{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:42:51Z","timestamp":1785278571227,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the clinical characteristics and risk factors of common systemic rheumatism concomitant with tuberculosis (TB).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 3,906 patients of RA, SLE, and SS diagnosed in the People's Hospital of Sichuan Province from January 2007 to January 2017 were collected. One hundred and five patients with TB were included as TB group, including 42 RA, 41 SLE, and 22 SS patients. In the non-TB group, 84 RA, 82 SLE, and 44 SS patients were randomly selected during the same period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fever was the most common symptom among RA, SLE, and SS patients with TB, accounting for 83.3%, 92.7%, and 68.2%, respectively. Cough, weight loss or fatigue were the next common. RA patients with TB were mostly pulmonary TB (PTB), accounting for 64.3%. The proportion of PTB for SLE and SS were 46.3%, 59.01%, respectively. In TB group, 59% RA, 57% SLE, and 62% SS with PTB had two or more chest CT findings. There were 48 TB cases received both Interferon Gamma Release Assay (IGRA) and Tuberculin skin test (TST) with positive rates of 91.8%, 45.8%, respectively. The daily average dose of glucocorticoids within 1 year in TB group was higher than that in non-TB group of SLE patients, lower counts of CD4+ T cell count were found in TB group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05), while no such differences were found in RA and SS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>RA patients with TB are mainly pulmonary TB. For SLE and SS patients, the chance of PTB and extrapulmonary tuberculosis is similar. Daily average dose of glucocorticoids within 1 year may be a common risk factor for RA, SLE and SS patients developing TB. Decreased CD4+ T cell count may also be a risk factor for SLE patients with TB. Symptoms of RA, SLE, SS with TB, are similar with the primary disease or other infection. It is recommended to conduct both TST and IGRA to help diagnose TB.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.948652","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T04:46:00Z","timestamp":1673844360000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical characteristics and related influencing factors of common rheumatic diseases concomitant with tuberculosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Guo","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"e948","DOI":"10.1016\/S2468-2667(21)00203-6","article-title":"Ending tuberculosis in China: health system challenges","volume":"6","author":"Long","year":"2021","journal-title":"Lancet Public Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3238\/arztebl.2019.0729","article-title":"The diagnosis and treatment of tuberculosis","volume":"116","author":"Su\u00e1rez","year":"2019","journal-title":"Dtsch Arztebl Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e20190023","DOI":"10.1590\/1806-3713\/e20190023","article-title":"Latent tuberculosis infection in patients with rheumatic diseases","volume":"45","author":"Anton","year":"2019","journal-title":"J Bras Pneumol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/joim.13218","article-title":"Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study","volume":"290","author":"Xiao","year":"2021","journal-title":"J Intern Med."},{"key":"B6","first-page":"1397","article-title":"Rheumatoid arthritis and tuberculosis: time to take notice","volume":"30","author":"Gardam","year":"2003","journal-title":"J Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/medicina56080392","article-title":"Incidence of tuberculosis in inflammatory rheumatic diseases: results from a Lithuanian retrospective cohort study","volume":"56","author":"Miltiniene","year":"2020","journal-title":"Medicina (Kaunas)."},{"key":"B8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12916-016-0673-8","article-title":"Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis","volume":"14","author":"Singh","year":"2016","journal-title":"BMC Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","article-title":"EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases","volume":"72","author":"Duru","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","article-title":"Tuberculosis: advances and challenges in development of new diagnostics and biomarkers","volume":"18","author":"Walzl","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1159\/000512531","article-title":"Post-tuberculosis lung disease: clinical review of an under-recognised global challenge","volume":"100","author":"Allwood","year":"2021","journal-title":"Respiration."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1080\/22221751.2021.2004864","article-title":"Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China","volume":"10","author":"Liu","year":"2021","journal-title":"Emerg Microbes Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/BOR.0000000000000493","article-title":"The interplay between tuberculosis and systemic lupus erythematosus","volume":"30","author":"Balbi","year":"2018","journal-title":"Curr Opin Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/ard.2005.047274","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan","volume":"65","author":"Yamada","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10067-013-2408-y","article-title":"Tuberculosis infection in primary Sj\u00f6gren's syndrome: a nationwide population-based study","volume":"33","author":"Chang","year":"2014","journal-title":"Clin Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0176549","DOI":"10.1371\/journal.pone.0176549","article-title":"Association between a history of mycobacterial infection and the risk of newly diagnosed Sj\u00f6gren's syndrome: a nationwide, population-based case-control study","volume":"12","author":"Chao","year":"2017","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/acr.23487","article-title":"Tuberculosis risk in ankylosing spondylitis, other spondyloarthritis, and psoriatic arthritis in Sweden: a population-based cohort study","volume":"70","author":"de Vries","year":"2018","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0178035","DOI":"10.1371\/journal.pone.0178035","article-title":"The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: a 15-year real world experience in Taiwan","volume":"12","author":"Lim","year":"2017","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"6","author":"Kay","year":"2012","journal-title":"Rheumatology (Oxford)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2032s syndrome: a revised version of the European criteria proposed by the American-European ConsensusGroup","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3969\/j.issn.1671-9638.2018.04.019","article-title":"Classification of tuberculosis (WS196-2017)","volume":"17","year":"2018","journal-title":"Chin J Infect Control"},{"key":"B24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3969\/j.issn.1671-9638.2018.07.019","article-title":"Diagnosis for pulmonary tuberculosis (WS288-2017)","volume":"17","year":"2018","journal-title":"Chin J Infect Control"},{"key":"B25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/ijms18020293","article-title":"Lung infections in systemic rheumatic disease: focus on opportunistic infections","volume":"18","author":"Di Franco","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.semarthrit.2011.11.002","article-title":"Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s","volume":"41","author":"Mak","year":"2012","journal-title":"Semin Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","article-title":"Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review","volume":"78","author":"Baronnet","year":"2011","journal-title":"Joint Bone Spine."},{"key":"B28","first-page":"127","article-title":"The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea","volume":"20","author":"Yun","year":"2002","journal-title":"Clin Exp Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2324709618770226","DOI":"10.1177\/2324709618770226","article-title":"Miliary tuberculosis presenting with meningitis in a patient treated with mycophenolate for lupus nephritis: challenges in diagnosis and review of the literature","volume":"6","author":"Macauley","year":"2018","journal-title":"J Investig Med High Impact Case Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1177\/0961203317722849","article-title":"Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report","volume":"27","author":"Cooray","year":"2018","journal-title":"Lupus."},{"key":"B32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/030097402760375205","article-title":"Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong","volume":"31","author":"Tam LS Li","year":"2002","journal-title":"Scand J Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/23744235.2019.1682187","article-title":"High risk of activation of latent tuberculosis infection in rheumatic disease patients","volume":"52","author":"Long","year":"2020","journal-title":"Infect Dis (Lond)."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/annrheumdis-2013-204960","article-title":"Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?","volume":"74","author":"Arkema","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-020-00667-6","article-title":"Of tuberculosis and non-tuberculous mycobacterial infections\u2014a comparative analysis of epidemiology, diagnosis and treatment","volume":"27","author":"Gopalaswamy","year":"2020","journal-title":"J Biomed Sci."},{"key":"B36","first-page":"9","article-title":"Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population","volume":"16","author":"Kim","year":"1998","journal-title":"Clin Exp Rheumatol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.948652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T04:46:05Z","timestamp":1673844365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.948652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":36,"alternative-id":["10.3389\/fpubh.2022.948652"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.948652","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"article-number":"948652"}}